Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07).
Journal: Nature communications
Published: July 28, 2020
Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition.
Journal: Gynecologic oncology
Published: June 29, 2020
Association of PD-L1 expression by immunohistochemistry and gene microarray with molecular subtypes of ovarian tumors.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 22, 2020
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.
Journal: The Journal of steroid biochemistry and molecular biology
Published: January 30, 2019
MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer.
Journal: Molecular cancer therapeutics
Published: October 29, 2017
Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi.
Journal: Genes, chromosomes & cancer
Published: December 12, 2016
Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression.
Journal: Cancer letters
Published: December 09, 2016
Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer.
Journal: British journal of cancer
Published: November 19, 2015
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 22, 2015
ADRM1-amplified metastasis gene in gastric cancer.
Journal: Genes, chromosomes & cancer
Published: January 15, 2015
Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer.
Journal: Journal of the National Cancer Institute
Published: October 02, 2014
Last Updated: 09/26/2026